North Macedonia cannabis disruptor with EU-GMP compliant facility for purchase!
State of the art, low-cost manufacturing facility in North Macedonia with access to the supply chain and contracts in place seeks full sale. Poised to drive value creation in the rapidly growing global medicinal cannabis market.
Listing ID:
18598094464
Licence(s) Held:
Regulatory license held for the manufacturing, R&D, processing, packaging and import/ export of medicinal cannabis globally includes flower, extracts and final product - no volume limitations
Seeking outright divestiture of the wholly owned land and building, licences, and going-concern business for €6,950,000. Option to lease the licenced land parcel.
Listing Details:
Fully licensed, ~2,500 m² EU GMP compliant pharmaceutical facility for the manufacturing, R&D, processing, packaging and import/ export of medicinal cannabis globally includes flower, extracts and final product
25 acres of commercial land owned and 5 acres are licensed for production (greenhouse or indoor) and outdoor cultivation
Facility is capable of tolling 1000 KG’s of dried flower per month (i.e. GACP to GMP conversion), extraction capacity of 130 lts per month (EU-GMP), internal cultivation of 100kg per month (EU GMP), outdoor cultivation minimum potential of 4,000KGs per annum and further capabilities for packaging, white labeling, finished product, and stability chambers
Current facility has the capacity for over €20m of annual production
Urban plan and taxes paid for an additional 13,000sqm production space leading to a minimum of €100m p.a. of additional capacity
World-class, EU GMP trained team with domain and industry leadership spanning medical, pharmaceuticals, technology and cannabinoids
Have established a number of key relationships with clinics, distributors, university partners and other commercial partners
Commercial partnerships UK / Poland / Germany / Australia
Built and growing an €18m pipe lineDiversified supply agreements are in place and multiple LOIs/contracts are underway
Exclusive contract for cannabis cultivation and supply to a UK cannabinoid FDA Botanical Pathway Drug Development company
Company has been awarded two local government grant contracts, R&D tax rebates., and local bank lending with 10% corporation tax
26% rebate on CAPEX
Strategically positioned as a key gateway for importing and exporting cannabis and cannabis products to and from Europe, poised to emerge as a prominent force in pioneering cannabinoid-based medication and technology within the European and global cannabis industries
Seeking outright divestiture of the wholly owned land and building, licences, and going-concern business in North Macedonia. There is an option to acquire additional cannabinoid/IP assets from the UK parent company.
18598094464
NEW CANNABIS BUSINESSES FOR SALE
See the latest cannabis business listings on the market including dispensaries, cultivation facilities, greenhouses, labs, and more. If you're looking to invest, acquire, or expand, these business opportunities provide the perfect starting point to grow your footprint in the cannabis industry.
36324927098
Licensed Colombian medical cannabis platform targeting EU pharmaceutical market seeks $3M equity partner
Premium, fully licensed Colombian cannabis cultivation platform offering pharmaceutical-grade production at industry-leading costs, with secured European market access and scalable growth potential
29345918591
State-of-the-art, ~130,000 sq. ft. production facility with 20.5 tonnes annual capacity and & EU-GMP designed processing hub
Opportunity to acquire a custom-designed, ~130,000 sq. ft. turnkey production asset including 84,000 square feet of canopy designed for pharmaceutical-grade output. This unique opportunity allows for a clean-slate acquisition of world-class infrastructure providing an immediate entry point into the global medicinal and premium international markets.